News
Important Only
ImmuCell Q4 preliminary sales dip
OverviewAnimal health company's preliminary Q4 sales declined 1.6% yr/yrDomestic sales rose 8.7%, while international sales fell 52.6%OutlookCompany focuses on expanding First Defense capacity after pausing Re-Tain investmentImmuCell plans manufacturing improvements to support First Defense grow...Reuters
Thu, Jan 8
Canada's Aritzia Q3 adjusted EPS beats estimates, partly helped by e-commerce growth
OverviewFashion retailer's fiscal Q3 revenue rose 42.8%, driven by digital and boutique growthAdjusted EPS for fiscal Q3 beat analyst expectationsAdjusted net income for fiscal Q3 beat analyst expectationsOutlookAritzia expects Q4 net revenue between C$1.100 bln and C$1.125 blnCompany anticipate...Reuters
Thu, Jan 8
CORRECTED-US House fails to overturn Trump veto of Colorado water project
WASHINGTON, Jan 8 (Reuters) - The Republican-led U.S. House of Representatives on Thursday fell short of the two-thirds supermajority required to override President Donald Trump's veto of a drinking-water project in Colorado.Reuters
Thu, Jan 8
Aehr Test Systems Q2 revenue misses estimates
OverviewSemiconductor test supplier's fiscal 2026 Q2 revenue fell, missing analyst expectationsCompany swings to a loss in Q2 vs same period last yearOutlookAehr expects second-half fiscal 2026 revenue between $25 mln and $30 mlnCompany forecasts second-half fiscal 2026 non-GAAP net loss per sha...Reuters
Thu, Jan 8
Beta Bionics preliminary Q4 net sales rise
OverviewDiabetes management firm's preliminary Q4 net sales rose, beating analyst expectationsDME channel net sales expected to rise 23% yr/yr in the quarterPBP channel net sales expected to rise yr/yrOutlookCompany did not provide specific guidance for future quarters or full year 2026Result Dr...Reuters
Thu, Jan 8
COPT Defense Executes 132,000 Square Foot Build-to-Suit Lease in San Antonio
Jan 8 (Reuters) - Copt Defense Properties CDP.N:COPT DEFENSE EXECUTES 132,000 SQUARE FOOT BUILD-TO-SUIT LEASE IN SAN ANTONIO, BRINGING NEW INVESTMENTS IN 2025 TO $277 MILLIONCOPT DEFENSE PROPERTIES - CONSTRUCTION ON 132,000 SQ FT FACILITY TO START Q3 2026Reuters
Thu, Jan 8
Frontline Announces Strategic Fleet Renewal Initiative
Jan 8 (Reuters) - Frontline Plc HF6.F:FRONTLINE PLC - ANNOUNCES STRATEGIC FLEET RENEWAL INITIATIVEFRONTLINE PLC - TO SELL EIGHT ECO VLCCS FOR $831.5 MILLIONFRONTLINE PLC: DELIVERY OF ECO VLCCS TO NEW OWNER SCHEDULED DURING Q1 OF 2026FRONTLINE PLC - TO BUY NINE ECO VLCCS FOR $1,224 MILLIONReuters
Thu, Jan 8
EACO Q1 net sales rise 18%
OverviewElectronics distributor's fiscal Q1 net sales rose 18.1% yr/yr to record levelsNet income for fiscal Q1 increased 35.3% yr/yr, reaching a record highCompany anticipates continued growth in headcount and sales teams in fiscal 2026OutlookCompany anticipates continued growth in headcount an...Reuters
Thu, Jan 8
Kalvista Pharma Provides Update On Strong EKTERLY Launch
Jan 8 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:KALVISTA PHARMACEUTICALS PROVIDES UPDATE ON STRONG EKTERLY® LAUNCH WITH PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 REVENUE RESULTSKALVISTA PHARMACEUTICALS INC - EKTERLY GENERATES $35 MILLION IN Q4 REVENUEReuters
Thu, Jan 8
WD-40 Q1 net sales rise on gross margin improvement
OverviewGlobal maintenance product firm's Q1 net sales rose 1% yr/yrQ1 net income decreased 8% yr/yrDiluted EPS for Q1 fell 8% yr/yrOutlookWD-40 reaffirms fiscal 2026 guidance, expects results toward mid-to-high end of rangesCompany projects fiscal 2026 net sales between $630 mln and $655 mlnWD-...Reuters
Thu, Jan 8
US appeals court revives Seagate antitrust claims against Japan’s NHK Spring
By Mike Scarcella WASHINGTON, Jan 8 (Reuters) - Data storage company Seagate STX.O on Thursday persuaded a U.S. appeals court to revive key claims in a lawsuit accusing Japanese manufacturer NHK Spring of illegally fixing the prices of key technology parts.The San Francisco-based 9th U.S. Circuit...Reuters
Thu, Jan 8
Simulations Plus Q1 revenue beats expectations
OverviewDrug development firm's fiscal Q1 revenue decreased 3%, beating analyst expectationsAdjusted EPS for fiscal Q1 met analyst expectationsCompany reaffirmed fiscal 2026 guidance and plans Investor Day for new product visionOutlookSimulations Plus reaffirms fiscal 2026 revenue guidance of $7...Reuters
Thu, Jan 8
Pacira 2025 preliminary revenue slightly misses expectations
OverviewNon-opioid pain therapy firm's preliminary 2025 revenue slightly missed analyst expectationsEXPAREL sales volume grew 7% in Q4, marking strongest performance in three yearsCompany repurchased 2 mln shares for $50 mln in Q4OutlookCompany did not provide specific financial guidance for 202...Reuters
Thu, Jan 8
Krystal Biotech Announces Positive Interim Clinical Update From KB407 Phase 1 CORAL-1 Study
Jan 8 (Reuters) - Krystal Biotech Inc KRYS.O:KRYSTAL BIOTECH ANNOUNCES POSITIVE INTERIM CLINICAL UPDATE FROM KB407 PHASE 1 CORAL-1 STUDY WITH CONFIRMATION OF WILD-TYPE CFTR DELIVERY TO THE LUNGS OF PATIENTS WITH CYSTIC FIBROSISKRYSTAL BIOTECH INC - SERIOUS ADVERSE EVENT OF ASTHMA EXACERBATION REPORT...Reuters
Thu, Jan 8
